Sameh Elokazi

Sameh Elokazi has a diverse work experience in the fields of healthcare and pharmaceuticals.

From 2019 to present, Sameh has been working at Capital Health, where they hold the position of Director of Business Development, Marketing and Communications. In this role, Sameh is responsible for managing commercial operations and strategy for Capital Health Group. Sameh develops corporate strategy and growth plans, oversees multiple teams, and collaborates with key stakeholders.

Prior to joining Capital Health, Sameh worked at Cambridge Medical & Rehabilitation Center from 2018 to 2019 as a Business Development Manager. Sameh was responsible for developing growth strategies, building strategic partnerships, and managing a team of Business Development Executives.

Sameh also has extensive experience at Novartis, where they held multiple roles. Sameh served as a First Line Sales Manager from 2008 to 2018, leading and developing a team of Medical Representatives. Sameh also worked as a Governmental sector / MoH KAM Manager, where they managed a team of Key Account Manager Associates and implemented strategies for market access. In addition, Sameh worked as a Key Accounts Manager, managing Novartis' portfolio business in key accounts and building professional relationships with payers. Before that, they worked as a Transplantation & Immunology Specialist, promoting Novartis' transplantation portfolio in various healthcare settings. Sameh began their career at Novartis as a Medical Representative.

In 2016, Sameh served as a member of the Research Abstract Review Committee at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Overall, Sameh Elokazi has a strong background in business development, marketing, strategic planning, and team management across the healthcare and pharmaceutical sectors.

Sameh Elokazi attended Alexandria University from 2003 to 2008 where they earned a degree in Veterinary Medicine. Sameh graduated with a good standing in their field of study. In addition to their formal education, Sameh has obtained additional certifications. In 2014, they completed a course on Finance for non Financial Managers at the American Chamber of Commerce in Egypt. In 2016, they became a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).